Sphera Funds Management Ltd. Replimune Group, Inc. Transaction History

Sphera Funds Management Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$6.75 - $16.18 $1.14 Million - $2.73 Million	-168,920 Reduced 91.3%	16,096 $135,000
Q3 2023 Nov 14, 2023	BUY	$15.96 - $22.18 $2.95 Million - $4.1 Million	185,016 New	185,016 $3.17 Million
Q2 2022 Aug 15, 2022	SELL	$13.32 - $19.98 $2.83 Million - $4.25 Million	-212,640 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$15.24 - $29.75 $3.24 Million - $6.33 Million	212,640 New	212,640 $3.61 Million

149

68M

52.3K

80.3K

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $631M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.